Vicor Technologies Inc.

• Public
• US

Dow Jones Description

We are a medical diagnostics company focused on commercializing noninvasive diagnostic technology products based on our patented, proprietary point correlation dimension algorithm (the PD2i Algorithm) and software. The PD2i Algorithm facilitates the ability to accurately risk stratify a specific target population to predict future pathological events. We believe that the PD2i Algorithm and software represents a noninvasive monitoring technology that physicians and other members of the medical community can use as a new and accurate vital sign. We are currently commercializing three proprietary diagnostic medical products which employ software utilizing the PD2i algorithm: the PD2i Analyzer, the PD2i- VS (Vital Sign) and the PD2i Cardiac Analyzer. It is also anticipated that the PD2i Algorithm applications will allow for the early detection of Alzheimers Disease and other disorders and diseases. Our first product, the PD2i Analyzer, displays and analyzes electrocardiographic (ECG) information that measures heart rate variability (HRV). The PD2i Analyzer received 510(k) marketing clearance from the Food and Drug Administration (FDA) on December 29, 2008. Accordingly, we will be able to market and distribute the PD2i Analyzer for use by physicians and others in the medical community by, among other means, the sale of a private label ECG machine utilizing the PD2i Analyzer software.

Number of Employees 7

Contact Information

Peer Companies

• 3M Co.
• Baxter International Inc.
• Olympus Corp.
• Boston Scientific Corp.
• Becton, Dickinson and Co.
• All Companies